AYTU BioPharma to Present at Lytham Partners Spring 2026 Investor Conference

AYTU BioPharma, Inc. will take part in the Lytham Partners Spring 2026 Investor Conference on May 28. The company specialises in developing treatments for complex central nervous system diseases. Its aim is to improve patient quality of life through innovative medicines. AYTU BioPharma focuses on advancing medications for difficult neurological conditions. One of its key products is EXXUM, extended-release tablets for major depressive disorder. The firm also ensures patients can access its treatments through strong support programmes.

At the conference, the company will deliver a webcast presentation at 9:15 AM Eastern Time. Management will also hold virtual one-on-one meetings with investors throughout the event. The webcast can be viewed live on the conference website or via a direct link.

A replay of the presentation will be available after the event. It will also be posted on AYTU’s website under the Events & Presentations section. The conference provides a platform for AYTU BioPharma to engage with investors. The webcast and meetings aim to showcase the company’s work in neurological treatments. Access to the presentation will remain available online for later viewing.